Jennifer Goodin
Family · Mount Clemens, MINPI 1174129381
Payments from drug & device makers
Across 128 payments — averaging $16.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$287
- Novo Nordisk$285
- AbbVie$215
- Amarin Pharma, Inc.$185
- Sanofi-aventis U.S. LLC$158
- Biohaven Pharmaceuticals, Inc.$103
- plus $859 from 22 others
What the payments were for
- Food & beverage$2,092100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 13 | $287 |
| Novo Nordisk | 22 | $285 |
| AbbVie | 21 | $215 |
| Amarin Pharma, Inc. | 10 | $185 |
| Sanofi-aventis U.S. LLC | 8 | $158 |
| Biohaven Pharmaceuticals, Inc. | 6 | $103 |
| GSK | 5 | $100 |
| Bayer | 4 | $79 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $71 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $63 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $57 |
| Johnson & Johnson | 4 | $56 |
| Paratek Pharmaceuticals, Inc. | 3 | $49 |
| Pfizer | 3 | $45 |
| Exact Sciences | 2 | $41 |
| Lilly USA, LLC | 3 | $40 |
| Regeneron Healthcare Solutions, Inc. | 1 | $39 |
| AstraZeneca | 2 | $33 |
| Edwards Lifesciences | 1 | $25 |
| Idorsia Pharmaceuticals US Inc | 1 | $22 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $21 |
| Lundbeck LLC | 1 | $21 |
| Orexo US, Inc. | 1 | $21 |
| Novartis | 1 | $20 |
| Merck | 1 | $15 |
| Medtronic | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Eisai Inc. | 1 | $13 |
How this compares
$2,092 in reported general payments places this provider in the 80th percentile of 3,657 family providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 11 | $9,824 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $7,507 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 11 | $5,414 |
| Ventolin HfaAlbuterol Sulfate | 23 | $1,351 |
| Atorvastatin Calcium | 63 | $919 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 23 | $613 |
| Ibuprofen | 45 | $493 |
| Lisinopril | 46 | $475 |
| Pantoprazole Sodium | 24 | $438 |
| Levothyroxine Sodium | 25 | $292 |
| Omeprazole | 19 | $259 |
| Losartan Potassium | 24 | $248 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 11 | $247 |
| Fluticasone Propionate | 21 | $219 |
| Quetiapine Fumarate | 16 | $211 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta | $100 | $12,92223 claims |
| Novo NordiskOzempic | $285 | $9,82411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,657 family providers in Michigan.
Other family in Mount Clemens
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
- Rachael CompeauFlint$62K
- David KocendaLapeer$49K
- Tracy RobertsonBay City$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.